Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Healthy Living Partnership to Prevent Diabetes
Translating Research Into the Prevention of Diabetes Mellitus (TRIP DM)
Status: Enrolling
Updated:  12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Healthy Living Partnership to Prevent Diabetes
Translating Research Into the Prevention of Diabetes Mellitus (TRIP DM)
Status: Enrolling
Updated: 12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate
Status: Enrolling
Updated:  12/31/1969
Harbor UCLA Medical Center
mi
from
Torrance, CA
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate
Status: Enrolling
Updated: 12/31/1969
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge
A Study of Racial Differences in Natriuretic Peptides Response to Glucose Challenge
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge
A Study of Racial Differences in Natriuretic Peptides Response to Glucose Challenge
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated:  12/31/1969
Duke Early Phase Clinical Research
mi
from
Durham, NC
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated: 12/31/1969
Duke Early Phase Clinical Research
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
A Phase 2, Multicenter, Randomized, Single-Blind, Placebo-Controlled Cross-over Study to Assess the Efficacy and Safety of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated:  12/31/1969
MeBO Research
mi
from
Miami, FL
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated: 12/31/1969
MeBO Research
mi
from
Miami, FL
Click here to add this to my saved trials
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated:  12/31/1969
MeBO Research LTD
mi
from
London,
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated: 12/31/1969
MeBO Research LTD
mi
from
London,
Click here to add this to my saved trials
Fit-One: A Trial Evaluating the Effect of One Drop and Fitbit on Diabetes and Pre-diabetes Outcomes
Fit-One: A Randomized Waitlist Controlled Trial Evaluating the Effect of One Drop and Fitbit on Diabetes and Pre-diabetes Outcomes
Status: Enrolling
Updated:  12/31/1969
One Drop
mi
from
New York, NY
Fit-One: A Trial Evaluating the Effect of One Drop and Fitbit on Diabetes and Pre-diabetes Outcomes
Fit-One: A Randomized Waitlist Controlled Trial Evaluating the Effect of One Drop and Fitbit on Diabetes and Pre-diabetes Outcomes
Status: Enrolling
Updated: 12/31/1969
One Drop
mi
from
New York, NY
Click here to add this to my saved trials
The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism
The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism
Status: Enrolling
Updated:  12/31/1969
Franklin Institute of Wellness
mi
from
Franklin, TN
The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism
The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism
Status: Enrolling
Updated: 12/31/1969
Franklin Institute of Wellness
mi
from
Franklin, TN
Click here to add this to my saved trials
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated:  12/31/1969
Mass General Hospital Translational and Clinical Research Centers
mi
from
Boston, MA
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated: 12/31/1969
Mass General Hospital Translational and Clinical Research Centers
mi
from
Boston, MA
Click here to add this to my saved trials
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated:  12/31/1969
Mayo Gastroenterology Research Unit
mi
from
Rochester, MN
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated: 12/31/1969
Mayo Gastroenterology Research Unit
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated:  12/31/1969
Prism Clinical Research
mi
from
Saint Paul, MN
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
A Phase 1, First-in-Human, 2-Part, Multicenter Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling
Updated: 12/31/1969
Prism Clinical Research
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Weight Loss Using a Feedback Device in Obese People With the Metabolic Syndrome
What is the Effect of a Feedback Device on Weight Loss and Metabolic Measurements in Obese People With the Metabolic Syndrome?
Status: Enrolling
Updated:  12/31/1969
Rockefeller University
mi
from
New York, NY
Weight Loss Using a Feedback Device in Obese People With the Metabolic Syndrome
What is the Effect of a Feedback Device on Weight Loss and Metabolic Measurements in Obese People With the Metabolic Syndrome?
Status: Enrolling
Updated: 12/31/1969
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
A Phase 4, Open-Label, Single-Center Clinical Study of Extended Use of rhPTH(1-84) in Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
A Phase 4, Open-Label, Single-Center Clinical Study of Extended Use of rhPTH(1-84) in Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Pharmax Research Clinic
mi
from
Miami, FL
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Pharmax Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Regional Urology
mi
from
Shreveport, LA
Efficacy of an Intranasal Testosterone Product
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
Comparison of I-124 and I-131 Radiopharmacokinetics In Patient With Well Differentiated Thyroid Cancer After Thyroid Hormone Withdrawal
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
Comparison of I-124 and I-131 Radiopharmacokinetics In Patient With Well Differentiated Thyroid Cancer After Thyroid Hormone Withdrawal
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Solaris Clinical Research
mi
from
Meridian, ID
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Solaris Clinical Research
mi
from
Meridian, ID
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Carl R. Meisner Medical Clinic
mi
from
Sugar Land, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Carl R. Meisner Medical Clinic
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Valley Clinical Trials
mi
from
Northridge, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Valley Clinical Trials
mi
from
Northridge, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Endocrine Associates of Florida, P.A.
mi
from
Ocoee, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Endocrine Associates of Florida, P.A.
mi
from
Ocoee, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Juno Research
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Juno Research
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Manassas Clinical Research Center
mi
from
Manassas, VA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Manassas Clinical Research Center
mi
from
Manassas, VA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
San Marcus Research Clinic
mi
from
Miami Lakes, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
San Marcus Research Clinic
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Leon Medical Research
mi
from
Miami, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Leon Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Rockwood Medical Clinic
mi
from
Fort Worth, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Rockwood Medical Clinic
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Endocrine Associates
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Endocrine Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Diabetes Associates Medical Group
mi
from
Orange, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Diabetes Associates Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
East-West Medical Research Institute
mi
from
Honolulu, HI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Associated in Endocrinology
mi
from
Elgin, IL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Associated in Endocrinology
mi
from
Elgin, IL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Carteret Medical Group, LLC
mi
from
Morehead City, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Carteret Medical Group, LLC
mi
from
Morehead City, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Aventiv Research- Phoenix
mi
from
Mesa, AZ
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Aventiv Research- Phoenix
mi
from
Mesa, AZ
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Pines Care Research Center, LLC
mi
from
Pembroke Pines, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Pines Care Research Center, LLC
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Hanson Clinical Research Ctr
mi
from
Port Charlotte, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Hanson Clinical Research Ctr
mi
from
Port Charlotte, FL
Click here to add this to my saved trials